NO973531D0 - Use of melatonin for the treatment of patients suffering from drug addiction - Google Patents

Use of melatonin for the treatment of patients suffering from drug addiction

Info

Publication number
NO973531D0
NO973531D0 NO973531A NO973531A NO973531D0 NO 973531 D0 NO973531 D0 NO 973531D0 NO 973531 A NO973531 A NO 973531A NO 973531 A NO973531 A NO 973531A NO 973531 D0 NO973531 D0 NO 973531D0
Authority
NO
Norway
Prior art keywords
melatonin
treatment
patients suffering
drug addiction
addiction
Prior art date
Application number
NO973531A
Other languages
Norwegian (no)
Other versions
NO973531L (en
NO312814B1 (en
Inventor
Nava Zisapel
Original Assignee
Neurim Pharma 1991
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/381,535 external-priority patent/US6469044B1/en
Application filed by Neurim Pharma 1991 filed Critical Neurim Pharma 1991
Publication of NO973531D0 publication Critical patent/NO973531D0/en
Publication of NO973531L publication Critical patent/NO973531L/en
Publication of NO312814B1 publication Critical patent/NO312814B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/404—Indoles, e.g. pindolol
    • A61K31/4045—Indole-alkylamines; Amides thereof, e.g. serotonin, melatonin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
NO19973531A 1995-02-01 1997-07-31 Use of melatonin in the manufacture of a drug for the treatment of patients suffering from drug dependence NO312814B1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/381,535 US6469044B1 (en) 1995-02-01 1995-02-01 Method for treating patients suffering from drug dependencies which lead to plasma melationin deficiencies
EP95303853A EP0724878B1 (en) 1995-02-01 1995-06-06 Use of melatonin for treating patients suffering from drug dependencies
PCT/IB1996/000082 WO1996023496A1 (en) 1995-02-01 1996-01-29 Use of melatonin for treating patients suffering from drug addiction

Publications (3)

Publication Number Publication Date
NO973531D0 true NO973531D0 (en) 1997-07-31
NO973531L NO973531L (en) 1997-09-30
NO312814B1 NO312814B1 (en) 2002-07-08

Family

ID=26140195

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19973531A NO312814B1 (en) 1995-02-01 1997-07-31 Use of melatonin in the manufacture of a drug for the treatment of patients suffering from drug dependence

Country Status (22)

Country Link
JP (1) JP4516159B2 (en)
CN (1) CN1083263C (en)
AT (1) AT408188B (en)
AU (1) AU695366B2 (en)
BG (1) BG62876B1 (en)
BR (1) BR9607169A (en)
CZ (1) CZ291349B6 (en)
DK (1) DK176081B1 (en)
EE (1) EE03384B1 (en)
FI (1) FI119586B (en)
IS (1) IS1980B (en)
LU (1) LU90118B1 (en)
LV (1) LV11940B (en)
MD (1) MD1716C2 (en)
NO (1) NO312814B1 (en)
NZ (1) NZ298878A (en)
PL (1) PL183148B1 (en)
SI (1) SI9620022A (en)
SK (1) SK284521B6 (en)
TR (1) TR199700723T1 (en)
TW (1) TW483757B (en)
WO (1) WO1996023496A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0016918A (en) 2000-01-05 2004-03-23 Neurim Pharma 1991 Process and formulation for treating antihypertensive resistance and related conditions
IL149377A (en) * 2002-04-28 2012-10-31 Neurim Pharma 1991 Pharmaceutical formulation comprising melatonin for the potentiation of the effect of hypnotic compounds
IL155666A (en) 2003-04-29 2013-12-31 Neurim Pharma 1991 Composition for treating insomnia
US9119846B2 (en) 2003-04-29 2015-09-01 Neurim Pharmaceuticals (1991) Ltd. Method and composition for enhancing cognition in alzheimer's patients
JP2015509106A (en) 2012-01-26 2015-03-26 ヴァンダ ファーマシューティカルズ インコーポレイテッ Treatment of circadian rhythm disorders
US11918557B2 (en) 2012-01-26 2024-03-05 Vanda Pharmaceuticals Inc. Treatment of circadian rhythm disorders
ES2805376T3 (en) 2012-12-18 2021-02-11 Vanda Pharmaceuticals Inc Tasimelteon for treating circadian rhythm disorders
US11090285B2 (en) 2013-11-12 2021-08-17 Vanda Pharmaceuticals Inc Treatment of circadian rhythm disorders
US10376487B2 (en) 2013-11-12 2019-08-13 Vanda Pharmaceuticals Inc. Method of treatment
EP3337462B1 (en) * 2016-10-31 2020-09-30 Neurim Pharmaceuticals Ltd. Melatonin mini-tablets and method of manufacturing the same

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0518468T3 (en) * 1991-05-09 2000-01-31 Neurim Pharma 1991 Melatonin-containing compositions
IT1251544B (en) * 1991-05-13 1995-05-17 Gabriele Biella PHARMACEUTICAL COMPOSITIONS ACTIVE IN THE THERAPY OF SLEEP DISORDERS INCLUDING MELATONIN OR A DERIVATIVE IN ASSOCIATION WITH A BENZODIAZEPINE DERIVATIVE

Also Published As

Publication number Publication date
FI973185A0 (en) 1997-07-31
TR199700723T1 (en) 1998-02-21
LU90118B1 (en) 1997-11-13
CZ291349B6 (en) 2003-02-12
CN1083263C (en) 2002-04-24
MD1716C2 (en) 2002-02-28
BG62876B1 (en) 2000-10-31
PL183148B1 (en) 2002-05-31
WO1996023496A1 (en) 1996-08-08
DK176081B1 (en) 2006-04-18
TW483757B (en) 2002-04-21
JPH10513177A (en) 1998-12-15
BR9607169A (en) 1997-11-11
LV11940B (en) 1998-05-20
DK89697A (en) 1997-07-30
AU695366B2 (en) 1998-08-13
ATA901396A (en) 2001-02-15
NO973531L (en) 1997-09-30
AU4457496A (en) 1996-08-21
SK284521B6 (en) 2005-05-05
SI9620022A (en) 1998-10-31
CZ240597A3 (en) 1998-01-14
AT408188B (en) 2001-09-25
FI119586B (en) 2009-01-15
SK103097A3 (en) 1998-01-14
MD970254A (en) 1999-05-31
IS1980B (en) 2005-01-14
CN1172431A (en) 1998-02-04
FI973185A (en) 1997-09-30
PL321630A1 (en) 1997-12-08
BG101803A (en) 1998-04-30
MX9705856A (en) 1998-07-31
EE03384B1 (en) 2001-04-16
JP4516159B2 (en) 2010-08-04
NZ298878A (en) 1999-05-28
LV11940A (en) 1998-01-20
EE9700166A (en) 1998-02-16
IS4532A (en) 1997-07-25
NO312814B1 (en) 2002-07-08
MD1716B2 (en) 2001-08-31

Similar Documents

Publication Publication Date Title
NO965377L (en) Indolinone compounds for the treatment of diseases
NO982172D0 (en) Use of epinastine for the treatment of pain
CY2007001I2 (en) MEDICINAL PREPARATION FOR USE IN THE TREATMENT OF DIABETES
EP1139746A4 (en) Compounds and methods for the treatment of airway diseases and for the delivery of airway drugs
NO20013958L (en) Medication for the treatment of high blood pressure
HK1001218A1 (en) Use of melatonin for treating patients suffering from drug dependencies
DE69620691T2 (en) Therapeutic agent for the treatment of hypercholesterolemia
NO973531L (en) Use of melatonin for the treatment of patients suffering from drug addiction
NO20003229D0 (en) Combination of benzocycloheptapyridine compounds and antineoplastic drugs for the treatment of proliferative diseases
NO975545D0 (en) Cell line that produces analgesic compounds for the treatment of pain
NO975660D0 (en) Use of benzimidazoles for the manufacture of a drug for the treatment of liver chemistry
IS4528A (en) Bicyclic derivatives of isothio urea useful therapeutic treatment
HUP9903348A3 (en) Transdermal therapeutic system (tts) for administering active substances for the teratment of drug dependency or drug addiction
NO973081D0 (en) Procedure for the Treatment of Chronic Progressive Vascular Diseases
NO995231D0 (en) Therapeutic treatment of skin disorders
NO20012106D0 (en) Drug for the treatment of bone pathobolism
NO994258L (en) Use of levobupivacaine for the treatment of facial migraines
DK0879054T3 (en) Use of pyrrolidione derivatives for the manufacture of drugs for the treatment of drug addiction
NO20014812L (en) Method of Providing Cosmetic / Medical Therapy
NO981822D0 (en) Use of the GAX protein for the treatment of cancer
NO973366D0 (en) Procedure for the treatment of multiple sclerosis
NO974529D0 (en) Device for the delivery of alfuzosin through the skin
NO20001894D0 (en) Use of TNF antagonists as drugs for the treatment of septic diseases
NO982562D0 (en) Composition for the treatment of pain
DE69840432D1 (en) MEDICAMENT FOR THE TREATMENT OF EYES

Legal Events

Date Code Title Description
MK1K Patent expired